Page last updated: 2024-11-08

leucrose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

leucrose: RN given refers to all (D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

leucrose : A glycosylfructose consisting of an alpha-D-glucopyranosyl residue joined to D-fructopyranose via a (1->5)-linkage. An isomer of sucrose. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID165577
SCHEMBL ID3832014
MeSH IDM0168140

Synonyms (21)

Synonym
leucrose
4B42CA92-416A-4C2C-BAAA-D31AD7F77B1F
d-glucopyranosyl-alpha(1-5)-d-fructopyranose
unii-yac4299isi
d-fructose, 5-o-alpha-d-glucopyranosyl-
yac4299isi ,
d-fructose, 5-o-.alpha.-d-glucopyranosyl-
470-16-6
5-o-.alpha.-d-glucopyranosyl-d-fructose
SCHEMBL3832014
n2-[n2-(1-l-threonyl-l-prolyl)-l-arginyl]-l-lysine diacetate salt
W-203595
(3s,4s,5r)-1,3,4,6-tetrahydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-hexan-2-one
(3s,4s,5r)-5-[(2r,3r,4s,5s,6r)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-1,3,4,6-tetrakis(oxidanyl)hexan-2-one
Q3237106
DXALOGXSFLZLLN-WTZPKTTFSA-N
DTXSID40992132
5-o-hexopyranosylhex-2-ulose
(3s,4s,5r)-1,3,4,6-tetrahydroxy-5-(((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)hexan-2-one
F81529
AKOS040752512

Research Excerpts

Overview

Leucrose is a novel noncariogenic disaccharide. It represents a highly promising sugar substitute for caries prevention.

ExcerptReferenceRelevance
"Leucrose is a novel noncariogenic disaccharide and thus represents a highly promising sugar substitute for caries prevention."( Cariological assessment of leucrose [D-glucopyranosyl-alpha(1----5)-D-fructopyranose] as a sugar substitute.
Imfeld, T; Siebert, G; Ziesenitz, SC, 1989
)
1.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (13.04)18.7374
1990's8 (34.78)18.2507
2000's10 (43.48)29.6817
2010's2 (8.70)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.61 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]